Kinsey Hill Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1651 E Nickerson Ave, Benton Harbor, MI 49022 Phone: 269-983-5833 |
Jessica Gaytan, MS SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1651 E Nickerson Ave, Benton Harbor, MI 49022 Phone: 269-876-5697 |
Jacqueline Schmitt Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1651 E Nickerson Ave, Benton Harbor, MI 49022 Phone: 269-983-5833 |
Anna Patricia Livingston Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1651 E Nickerson Ave, Benton Harbor, MI 49022 Phone: 269-983-5833 |
Christopher Lee Smith Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1651 E Nickerson Ave, Benton Harbor, MI 49022 Phone: 269-876-5697 |
Kathryn Vandermolen Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1651 E Nickerson Ave, Benton Harbor, MI 49022 Phone: 269-983-5833 Fax: 269-363-4630 |
Mrs. Victoria Lynn White, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1651 E Nickerson Ave, Benton Harbor, MI 49022 Phone: 269-983-5833 Fax: 269-983-7441 |
News Archive
Absorption Systems, a leader in testing drugs for ADMET (absorption, distribution, metabolism, excretion and toxicity), today introduced an extensively renovated surgical suite for preclinical medical device testing at the company's facility in San Diego, CA. Absorption Systems has long been recognized as a leader in drug testing and is experiencing increased demand for its medical device testing services as well.
Former U.S. Surgeon General Dr. David Satcher said this week that over 80,000 black Americans die every year because of disparities in health care. Despite government and public and insurance companies knowledge of this shortchange in health care for blacks, they have done little to improve the situation.
Researchers at the University of Illinois at Chicago have had preliminary success with a method of immunization intended to dissolve the plaques in brain tissue that are associated with Alzheimer's disease.
Researchers at Children's Hospital of Philadelphia have demonstrated that an experimental device can improve blood sugar control in patients who developed diabetes after their pancreas was removed to treat their hyperinsulinism, a genetic disease in which the pancreas produces too much insulin.
ReCor Medical, an emerging medical device company, announced today that its PARADISE (Percutaneous Renal Denervation System) ultrasound platform for achieving renal denervation has received the CE mark. PARADISE is designed to treat patients with 'resistant' hypertension, a major risk factor for cardiovascular disease.
› Verified 9 days ago